Tim Opler covers the trends, deals, valuations, and players in the oncology market.
Oncology Market Update
Stifel
Tim Opler
Research
82 Pages
Key Takeaways
Cancer Burden Massive: Global cancer deaths exceed ~10 million annually, with lung, colorectal, liver, stomach, and breast cancers representing the largest unmet treatment needs worldwide.
Precision Oncology Expanding: Modern oncology drug development increasingly targets specific molecular drivers (e.g., KRAS, HER2, EGFR), enabling more personalized treatments and improving response rates compared with traditional chemotherapy.
Next-Gen Modalities Rising: New therapeutic platforms such as antibody-drug conjugates (ADCs) and bispecific antibodies are rapidly gaining traction and are becoming major drivers of oncology pipeline innovation and licensing activity.